Table 1. Cohort Characteristics.
Characteristic | Patients, No. (%) (N = 1929) |
---|---|
Age at diagnosis, ya | |
Mean (SD) | 28 (8) |
Median (IQR) | 30 (23-35) |
Sexa | |
Female | 1049 (54.5) |
Male | 875 (45.5) |
Race | |
American Indian or Alaska Native | 5 (0.3) |
Asian | 227 (11.8) |
Black or African American | 157 (8.1) |
Native Hawaiian or Other Pacific Islander | 14 (0.7) |
White | 1184 (61.4) |
More than 1 race | 11 (0.6) |
Not documented | 293 (15.2) |
Otherb | 38 (2.0) |
Ethnicity | |
Hispanic or Latino | 514 (26.6) |
Not Hispanic or Latino | 762 (39.5) |
Not documented | 653 (33.9) |
Primary cancer sitea | |
Bone or soft tissue | 264 (13.7) |
Brain | 170 (8.8) |
Breast | 265 (13.8) |
Gastrointestinal tract | 369 (19.2) |
Genitourinary tract | 214 (11.1) |
Head, neck, or thyroid | 72 (3.7) |
Leukemia | 164 (8.5) |
Lung | 85 (4.4) |
Lymphoma | 119 (6.2) |
Melanoma or skin | 67 (3.5) |
Other | 136 (7.1) |
Stage at diagnosisa | |
I-III | 1119 (67.6) |
IV | 537 (32.4) |
Site of care | |
DFCI | 703 (36.4) |
KPNC | 526 (27.3) |
KPSC | 700 (36.3) |
Abbreviations: DFCI, Dana-Farber Cancer Institute; KPNC, Kaiser Permanente Northern California; KPSC, Kaiser Permanente Southern California.
Missing data: age at cancer diagnosis, n = 37; sex, n = 5; primary cancer site, n = 4; stage, n = 273.
Other races included declined to state and unknown.